Jeffrey Meyerhardt, MD, MPH

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS3
- SINCE2008

Cetuximab 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
January 2008 - April 2011
Rectal Neoplasms
Cetuximab
5-Fluorouracil
External Beam Pelvis Radiation Therapy



